Copy the page URI to the clipboard
Da Pieve, C.; Iley, J. N.; Perkins, A. and Missailidis, S.
(2006).
DOI: https://doi.org/10.1186/bcr1587
URL: http://www.springerlink.com/content/y517l64447ml85...
Abstract
Aptamers are novel oligonucleotide-based recognition molecules which can bind to almost any target, including extracellular proteins, antibodies, peptides and small molecules. Aptamers can be rapidly generated, and offer reduced immunogenicity, good tumour penetration, rapid uptake and clearance, and can thus be used as alternatives to monoclonal antibodies in molecular targeted radiotherapy and diagnostic imaging.
Viewing alternatives
Metrics
Public Attention
Altmetrics from AltmetricNumber of Citations
Citations from DimensionsItem Actions
Export
About
- Item ORO ID
- 26095
- Item Type
- Journal Item
- Extra Information
-
Breast Cancer Research Volume 8 Supplement 2, November 2006
Meeting abstracts
Breast cancer research: the past and the future
The Royal Society, London, UK
1 November 2006
Published online: 1 November 2006 - Academic Unit or School
-
Faculty of Science, Technology, Engineering and Mathematics (STEM) > Life, Health and Chemical Sciences
Faculty of Science, Technology, Engineering and Mathematics (STEM)
Other Departments > Other Departments
Other Departments - Copyright Holders
- © 2006 BioMed Central Ltd
- Related URLs
- Depositing User
- Sotiris Missailidis